EMAIL THIS PAGE TO A FRIEND

PloS one

The prolyl hydroxylase inhibitor dimethyloxalylglycine enhances dentin sialophoshoprotein expression through VEGF-induced Runx2 stabilization.


PMID 25369078

Abstract

Prolyl hydroxylase (PHD) inhibitors are suggested as therapeutic agents for tissue regeneration based on their ability to induce pro-angiogenic responses. In this study, we examined the effect of the PHD inhibitor dimethyloxalylglycine (DMOG) on odontoblast maturation and sought to determine the underlying mechanism using MDPC-23 odontoblast-like cells. DMOG significantly enhanced matrix mineralization, confirmed by alizarin red staining and by measurement of the calcium content. DMOG dose-dependently increased alkaline phosphatase activity and the expressions of dentin sialophosphoprotein (Dspp) and osteocalcin. To determine the underlying events leading to DMOG-induced Dspp expression, we analyzed the effect of DMOG on Runx2. Knockdown of Runx2 using siRNAs decreased Dspp expression and prevented DMOG-induced Dspp expression. DMOG enhanced the transcriptional activity and level of Runx2 protein but not Runx2 transcript, and this enhancement was linked to the inhibitory effects of DMOG on the degradation of Runx2 protein. The vascular endothelial growth factor (VEGF) siRNAs profoundly decreased the Runx2 protein levels and inhibited the DMOG-increased Runx2 protein. Recombinant VEGF protein treatment significantly and dose-dependently increased the transcriptional activity and level of the Runx2 protein but not Runx2 transcript. Dspp expression was also enhanced by VEGF. Last, we examined the involvement of the Erk mitogen-activated protein kinase and Pin1 pathway in VEGF-enhanced Runx2 because this pathway can regulate the stability and activity of the Runx2 protein. VEGF stimulated Erk activation, and the inhibitors of Erk and Pin1 hampered VEGF-enhanced Runx2 protein. Taken together, the results of this study provide evidence that DMOG can enhance Dspp expression through VEGF-induced stabilization of Runx2 protein, and thus, suggest that DMOG can be used as a therapeutic tool for enhancing odontoblast maturation in dental procedures.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV36678
Anti-RUNX2 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV36679
Anti-RUNX2 (AB2) antibody produced in rabbit, IgG fraction of antiserum, lyophilized powder
SAB1412189
ANTI-RUNX2 antibody produced in mouse, clone 6E1, purified immunoglobulin, buffered aqueous solution
SAB1412247
ANTI-RUNX2 antibody produced in mouse, clone 4E5, ascites fluid, buffered aqueous solution
SAB1412248
ANTI-RUNX2 antibody produced in mouse, clone 4D7, purified immunoglobulin, buffered aqueous solution
SAB1412249
ANTI-RUNX2 antibody produced in mouse, clone 4B4, purified immunoglobulin, buffered aqueous solution
SAB1412665
ANTI-RUNX2 antibody produced in mouse, clone 2B9, purified immunoglobulin, buffered aqueous solution
SAB1412666
ANTI-RUNX2 antibody produced in mouse, clone 1D2, purified immunoglobulin, buffered aqueous solution
SAB1412667
ANTI-RUNX2 antibody produced in mouse, clone 3F5, purified immunoglobulin, buffered aqueous solution
SAB1412668
ANTI-RUNX2 antibody produced in mouse, clone 4C8, purified immunoglobulin, buffered aqueous solution
HPA022040
Anti-RUNX2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106220
Anti-RUNX2 antibody produced in rabbit, affinity isolated antibody
I5385 Monoclonal Anti-Human IgG1 (Fab specific) [G1m(f)] antibody produced in mouse, clone SG-16, ascites fluid
I9388 Monoclonal Anti-Human IgG1 (Fc specific) antibody produced in mouse, clone HP-6001, ascites fluid
WH0000860M1
Monoclonal Anti-RUNX2 antibody produced in mouse, clone 1D8, purified immunoglobulin, buffered aqueous solution
AMAB90591
Monoclonal Anti-RUNX2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0232, purified immunoglobulin, buffered aqueous glycerol solution
SAB1403638
Monoclonal Anti-RUNX2 antibody produced in mouse, clone 4D5, purified immunoglobulin, buffered aqueous solution
AMAB90594
Monoclonal Anti-RUNX2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0235, purified immunoglobulin, buffered aqueous glycerol solution